CBDV
Cannabidivarin

How it occurs

A propyl analog related to CBD and found at low levels in some plants.

Relationship to other cannabinoids

Propyl analog related to CBD with limited human evidence.

What is established

CBDV is naturally occurring and has been studied in laboratory and early clinical research.

Commonly reported effects

Consumer reports are limited and no broad effect profile is established.

Anecdotal or marketing-led unless stated otherwise

What remains uncertain

No broad consumer-health benefits are established.

Evidence quality

Preclinical and limited clinical evidence.

Safety and potential interactions

Human interaction and long-term safety data are incomplete.

Vaporization relevance

Heating can change cannabinoid form and delivery, but laboratory boiling points do not define a universal device setting. Heater design, sensor position, airflow, material, load, and draw behavior all affect exposure. This entry makes no compound-specific temperature recommendation.

Legal and regulatory context

Depends on source, product, claims, and jurisdiction.

Dated source foundation

Direct authoritative sources reviewed 2026-08-20. These sources support the safety and regulatory boundaries of this draft; a scientific editor must still verify compound-specific claims against current peer-reviewed literature.

• FDA — Cannabis and cannabis-derived products: questions and answers ↗
• FDA — What to know about cannabis and CBD products ↗
• NIDA — Cannabis (Marijuana) ↗
• CDC — Cannabis frequently asked questions ↗

Related entries

CBD · THCV

← All encyclopedia entries